GTx-758
GTx-758 (tentative brand name Capesaris) is a synthetic nonsteroidal estrogen which is under development by GTx, Inc. for the treatment of advanced prostate cancer. As of 2016, it has completed two phase II clinical trials.
primaryTopic
GTx-758
GTx-758 (tentative brand name Capesaris) is a synthetic nonsteroidal estrogen which is under development by GTx, Inc. for the treatment of advanced prostate cancer. As of 2016, it has completed two phase II clinical trials.
has abstract
GTx-758 (tentative brand name ...... two phase II clinical trials.
@en
CAS number
938067-78-8
ChEMBL
FDA UNII code
406GR1485Z
PubChem
Wikipage page ID
51,640,697
page length (characters) of wiki page
Wikipage revision ID
991,946,673
Link from a Wikipage to another Wikipage
CAS number
ChEMBL
ChemSpiderID
34,954,411
IUPAC name
legal US
Investigational New Drug
@en
PubChem
46,861,578
routes of administration
SMILES
C1=CCO
@en
StdInChIKey
FBCQEUMZZNVQKD-UHFFFAOYSA-N
@en
synonyms
Capesaris
@en
wikiPageUsesTemplate
comment
GTx-758 (tentative brand name ...... two phase II clinical trials.
@en
label
GTx-758
@en